Foster City, CA, United States of America

Jianhong Wang

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Gilead Sciences, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianhong Wang. Retrieved from https://idiyas.com/inventor/jianhong-wang-zeja44c9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jianhong Wang: Innovator in Antiviral Drug Development

Introduction

Jianhong Wang is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of antiviral drug development, particularly in relation to HIV treatment. His work has led to advancements that are crucial for improving patient outcomes.

Latest Patents

Wang holds a patent for "Metabolites of bictegravir." This invention provides metabolites of the antiviral drug bictegravir, including compositions and salts thereof. These metabolites are useful in the prevention and/or treatment of HIV, as well as analytical methods related to the administration of bictegravir. He has 1 patent to his name.

Career Highlights

Jianhong Wang is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company known for its innovative therapies. His role at Gilead has allowed him to focus on developing effective treatments for viral infections, particularly HIV.

Collaborations

Wang has collaborated with talented colleagues such as Haolun Jin and Hyung-Jung Pyun. Their combined expertise has contributed to the success of various projects within the company.

Conclusion

Jianhong Wang's work in antiviral drug development exemplifies the impact of innovation in healthcare. His contributions are vital for advancing treatments that can improve the lives of those affected by HIV.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…